Estrogens and aging skin

Dermato-Endocrinology

Volumn 5, Issue 2, 2013, Pages 264-270

  Thornton, M Julie ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Aging; Estrogen; Menopause; Phytoestrogen; Serms; Skin; Wound healing

Indexed keywords

ADENYLATE CYCLASE; COLLAGEN TYPE 3; CYCLIC AMP; DOPACHROME TAUTOMERASE; EQUOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FRATAXIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; GENISTEIN; HORMONE RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPASE C; PHYTOESTROGEN; PLACEBO; PROCOLLAGEN; PROTEIN KINASE C; RALOXIFENE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SUPEROXIDE DISMUTASE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

AGED; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BASAL CELL CARCINOMA; BREAST CANCER; CANCER RISK; CELL PROLIFERATION; CHLOASMA; CUTANEOUS PARAMETERS; DIETARY INTAKE; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; EXTRACELLULAR MATRIX; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HAIR GROWTH; HORMONE SUBSTITUTION; HUMAN; IMMUNE RESPONSE; KERATINOCYTE; MENOPAUSAL SYNDROME; MENOPAUSE; NON MELANOMA SKIN CANCER; OXIDATIVE STRESS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SKIN ATROPHY; SKIN BLOOD VESSEL; SKIN DISEASE; SKIN FIBROBLAST; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; UTERUS CANCER; WOUND HEALING; WRINKLE;

EID: 84885143083     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.23872     Document Type: Review

References (47)

1. Allen E, Doisy EA. An ovarian hormone preliminary report on its localisation, extraction and partial purification, and action in test animals. JAMA 1923; 81:819-21; http://dx.doi.org/10.1001/ jama.1923.02650100027012
2. Wend K, Wend P, Krum SA. Tissue-specifc effects of loss of estrogen during menopause and aging. Front Endocrinol (Lausanne) 2012; 3:1-14; PMID:22654856
3. Simpson ER. Genetic mutations resulting in estrogen insufficiency in the male. Mol Cell Endocrinol 1998; 145:55-9; PMID:9922099; http://dx.doi.org/10. 1016/ S0303-7207(98)00169-5
4. Labrie F. Adrenal androgens and intracrinology. Semin Reprod Med 2004; 22:299-309; PMID:15635498; http://dx.doi.org/10.1055/s-2004-861547
5. Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol 2002; 11:487-502; PMID:12473056; http://dx.doi.org/10.1034/j.1600- 0625.2002.110601.x
6. Thornton MJ. Oestrogen functions in skin and skin appendages. Expert Opin Ther Targets 2005; 9:617-29; PMID:15948678; http://dx.doi. org/10.1517/ 14728222.9.3.617
7. Gustafsson JA. Estrogen receptor beta-a new dimension in estrogen mechanism of action. J Endocrinol 1999; 163:379-83; PMID:10588810; http://dx.doi. org/10.1677/joe.0.1630379
8. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001; 29:2905- 19; PMID:11452016; http://dx.doi.org/10.1093/ nar/29.14.2905
9. Webb P, Nguyen P, Kushner PJ. Differential SERM effects on corepressor binding dictate ERalpha activity in vivo. J Biol Chem 2003; 278:6912-20; PMID:12482846; http://dx.doi.org/10.1074/jbc. M208501200
10. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997; 277:1508-10; PMID:9278514; http:// dx.doi.org/10.1126/ science.277.5331.1508
11. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004; 25:45-71; PMID:14769827; http://dx.doi.org/10.1210/er.2003- 0023
12. Thornton MJ, Nelson LD, Taylor AH, Birch MP, Laing I, Messenger AG. The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta? J Invest Dermatol 2006; 126:2010-8; PMID:16691199; http://dx.doi.org/10.1038/sj.jid.5700344
13. Stevenson S, Thornton J. Effect of estrogens on skin aging and the potential role of SERMs. Clin Interv Aging 2007; 2:283-97; PMID:18044179
14. Levin ER. Minireview: Extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol 2011; 25:377-84; PMID:20861220; http://dx.doi. org/10.1210/me.2010-0284
15. Levin ER. G protein-coupled receptor 30: estrogen receptor or collaborator? Endocrinology 2009; 150:1563-5; PMID:19307418; http://dx.doi. org/10.1210/en.2008-1759
16. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 2007; 282:22278-88; PMID:17535799; http:// dx.doi.org/10.1074/jbc. M611877200
17. Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, Yue W. Estrogen signals Via an extra-nuclear pathway inVolVing IGF-1R and EGFR in tamoxifen-sensitiVe and -resistant breast cancer cells. Steroids 2009; 74:586- 94; PMID:19138696; http://dx.doi.org/10.1016/j. steroids.2008.11.020
18. Song RX, Fan P, Yue W, Chen Y, Santen RJ. Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer. Endocr Relat Cancer 2006; 13(Suppl 1):S3-13; PMID:17259556; http://dx.doi.org/10.1677/ erc.1.01322
19. Lebesgue D, Chevaleyre V, Zukin RS, Etgen AM. Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids 2009; 74:555-61; PMID:19428444; http://dx.doi.org/10. 1016/j.steroids.2009.01.003
20. Makrantonaki E, Vogel K, Fimmel S, Oeff M, Seltmann H, Zouboulis CC. Interplay of IGF-I and 17betaestradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol 2008; 43:939- 46; PMID:18755261; http://dx.doi.org/10.1016/j. exger.2008.07.005
21. Emmerson E, Campbell L, Davies FC, Ross NL, Ashcroft GS, Krust A, et al. Insulin-like growth factor-1 promotes wound healing in estrogendeprived mice: new insights into cutaneous IGF-1R/ ER? cross talk. J Invest Dermatol 2012; 132:2838- 48; PMID:22810305; http://dx.doi.org/10.1038/ jid.2012.228
22. Inoue T, Miki Y, Abe K, Hatori M, Hosaka M, Kariya Y, et al. The role of estrogen-metabolizing enzymes and estrogen receptors in human epidermis. Mol Cell Endocrinol 2011; 344:35-40; PMID:21740958; http://dx.doi.org/10.1016/j.mce. 2011.06.015
23. Punnonen R. Effect of castration and peroral estrogen therapy on the skin. Acta Obstet Gynecol Scand Suppl 1972; 21:3-44; PMID:4511789
24. Maheux R, Naud F, Rioux M, Grenier R, Lemay A, Guy J, et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 1994; 170:642-9; PMID:8116726
25. Son ED, Lee JY, Lee S, Kim MS, Lee BG, Chang IS, et al. Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating tgf-Beta signaling in aged human skin in vivo. J Invest Dermatol 2005; 124:1149-61; PMID:15955089; http://dx.doi.org/10.1111/j.0022-202X.2005. 23736.x
26. Brincat M, Versi E, Moniz CF, Magos A, de Trafford J, Studd JW. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987; 70:123-7; PMID:3601260
27. Brincat M, Moniz CJ, Studd JW, Darby A, Magos A, Emburey G, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92:256-9; PMID:3978054; http:// dx.doi.org/10.1111/j.1471- 0528.1985.tb01091.x
28. Affinito P, Palomba S, Sorrentino C, Di Carlo C, Bifulco G, Arienzo MP, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999; 33:239-47; PMID:10656502; http://dx.doi. org/10.1016/S0378-5122(99)00077-8
29. Sauerbronn AV, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000; 68:35-41; PMID:10687834; http://dx.doi.org/ 10.1016/S0020- 7292(99)00166-6
30. Savvas M, Bishop J, Laurent G, Watson N, Studd J. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993; 100:154-6; PMID:8476808; http://dx.doi. org/10.1111/j.1471-0528.1993.tb15212.x
31. Schmidt JB, Binder M, Demschik G, Bieglmayer C, Reiner A. Treatment of skin aging with topical estrogens. Int J Dermatol 1996; 35:669-74; PMID:8876303; http://dx.doi.org/10.1111/j.1365-4362.1 96. tb03701.x
32. Varila E, Rantala I, Oikarinen A, Risteli J, Reunala T, Oksanen H, et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102:985-9; PMID:8652490; http:// dx.doi.org/10.1111/j. 1471-0528.1995.tb10906.x
33. Shah MG, Maibach HI. Estrogen and skin. An overview. Am J Clin Dermatol 2001; 2:143-50; PMID:11705091; http://dx.doi.org/10.2165/00128071-200102030- 00003
34. Henry F, Piérard-Franchimont C, Cauwenbergh G, Piérard GE. Age-related changes in facial skin contours and rheology. J Am Geriatr Soc 1997; 45:220-2; PMID:9033524
35. Wolff EF, Narayan D, Taylor HS. Long-term effects of hormone therapy on skin rigidity and wrinkles. Fertil Steril 2005; 84:285-8; PMID:16084862; http://dx.doi. org/10.1016/j.fertnstert.2004.12.062
36. Emmerson E, Hardman MJ. The role of estrogen deficiency in skin ageing and wound healing. Biogerontology 2012; 13:3-20; PMID:21369728; http://dx.doi.org/10.1007/s10522-011-9322-y
37. Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet 2002; 359:675-7; PMID:11879867; http://dx.doi.org/10.1016/S0140-6736(02)07806-6
38. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MWJ. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999; 155:1137-46; PMID:10514397; http://dx.doi. org/10.1016/S0002-9440(10)65217-0
39. Ashcroft GS, Lei KJ, Jin WW, Longenecker G, Kulkarni AB, Greenwell-Wild T, et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000; 6:1147-53; PMID:11017147; http://dx.doi. org/10.1038/80489
40. Ashcroft GS, Horan MA, Herrick SE, Tarnuzzer RW, Schultz GS, Ferguson MWJ. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res 1997; 290:581-91; PMID:9369533; http://dx.doi. org/10.1007/s004410050963
41. Ashcroft GS, Mills SJ, Lei KJ, Gibbons L, Jeong MJ, Taniguchi M, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003; 111:1309- 18; PMID:12727922
42. Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997; 3:1209-15; PMID:9359694; http://dx.doi.org/10.1038/nm1197- 1209
43. Stevenson S, Taylor AH, Meskiri A, Sharpe DT, Thornton MJ. Differing responses of human follicular and nonfollicular scalp cells in an in vitro wound healing assay: effects of estrogen on vascular endothelial growth factor secretion. Wound Repair Regen 2008; 16:243-53; PMID:18318810; http://dx.doi. org/10.1111/j.1524-475X.2008.00365.x
44. Stevenson S, Nelson LD, Sharpe DT, Thornton MJ. 17beta-estradiol regulates the secretion of TGF-? by cultured human dermal fibroblasts. J Biomater Sci Polym Ed 2008; 19:1097-109; PMID:18644234; http://dx.doi.org/10. 1163/156856208784909354
45. Stevenson S, Sharpe DT, Thornton MJ. Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay. Exp Dermatol 2009; 18:988-90; PMID:19469894; http://dx.doi.org/10.1111/j.1600- 0625.2009.00864.x
46. Ohnemus U, Uenalan M, Inzunza J, Gustafsson JA, Paus R. The hair follicle as an estrogen target and source. Endocr Rev 2006; 27:677-706; PMID:16877675; http://dx.doi.org/10.1210/er.2006-0020
47. Lynfield YL. Effect of pregnancy on the human hair cycle. J Invest Dermatol 1960; 35:323-7; PMID:13764567